Skip to main content
. 2023 Jul 27;202(2):245–255. doi: 10.1007/s10549-023-07065-0

Table 3.

Results of sentinel node analysis in Mastectomy

Parameter Histology n = 10,097 % OSNA n = 375 % P-value
Macrometastasis 1927 19.1 65 17.3 0.396
Micrometastasis 1048 10.4 58 15.5 0.002
Axillary therapy* 0.591
 Yes 1828 18.11 75 20.00
 No 8264 81.8 300 80.0
 Unknown 5 0.05 0 0.0
 Axillary lymph node dissection 445 4.4 56 14.9  < 0.001
Axillary radiotherapy  < 0.001
 Yes 1383 13.7 19 5.1
 No 8709 86.3 356 94.9
 Unknown 5 0.05 0 0.0
Chemotherapy** 2471 24.5 96 25.6 0.618
Endocrine therapy 6194 61.3 211 56.3 0.048
Chemotherapy and endocrine therapy 1900 18.8 66 17.6 0.553
cT stage 0.188
 T1a/b 1539 15.2 61 16.3
 T1c 3826 37.9 150 40.0
 T2 3931 38.9 130 34.7
 T3 598 5.9 21 5.6
 Tx 203 2.0 13 3.5

Significant differences are bold

*Axillary lymph node dissection or axillary radiotherapy

**Chemotherapy with or without (targeted) immunotherapy. Statistical analysis was performed using Pearson Chi-square test